Using whole-genome sequencing data to derive the homologous recombination deficiency scores

[1]  J. Pearson,et al.  Using whole-genome sequencing data to derive the homologous recombination deficiency scores , 2020, npj Breast Cancer.

[2]  J. Pearson,et al.  Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  E. Birney,et al.  Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences , 2019, Nature.

[4]  Nicolai J. Birkbak,et al.  Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer , 2018, npj Breast Cancer.

[5]  Z. Szallasi,et al.  Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors , 2018, bioRxiv.

[6]  Nancy R. Zhang,et al.  BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers , 2017, Nature Communications.

[7]  J. Reis-Filho,et al.  Bi‐allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer , 2017, The Journal of pathology.

[8]  Nicholas J Monteleone,et al.  An evaluation of copy number variation detection tools for cancer using whole exome sequencing data , 2017, BMC Bioinformatics.

[9]  E. Birney,et al.  HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures , 2017, Nature Medicine.

[10]  Andrew Menzies,et al.  ascatNgs: Identifying Somatically Acquired Copy‐Number Alterations from Whole‐Genome Sequencing Data , 2016, Current protocols in bioinformatics.

[11]  Ignace Vergote,et al.  Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. , 2016, The New England journal of medicine.

[12]  L. Pusztai,et al.  Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer , 2016, Clinical Cancer Research.

[13]  Terry K Koo,et al.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. , 2016, Journal Chiropractic Medicine.

[14]  David C. Jones,et al.  Landscape of somatic mutations in 560 breast cancer whole genome sequences , 2016, Nature.

[15]  Z. Szallasi,et al.  Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer , 2016, Clinical Cancer Research.

[16]  D. Giavarina.  Understanding Bland Altman analysis , 2015, Biochemia medica.

[17]  Nicolai J. Birkbak,et al.  Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs , 2015, Biomarker Research.

[18]  Z. Szallasi,et al.  Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  Lei Shang,et al.  Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants , 2014, Proceedings of the National Academy of Sciences.

[20]  Alison M. Meynert,et al.  Variant detection sensitivity and biases in whole genome and exome sequencing , 2014, BMC Bioinformatics.

[21]  Xiaolin Zhu,et al.  An Evaluation of Copy Number Variation Detection Tools from Whole‐Exome Sequencing Data , 2014, Human mutation.

[22]  C. Ponting,et al.  Sequencing depth and coverage: key considerations in genomic analyses , 2014, Nature Reviews Genetics.

[23]  Heng Li.  Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[24]  A. Vincent-Salomon,et al.  Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation. , 2012, Cancer research.

[25]  G. Mills,et al.  Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer , 2012, British Journal of Cancer.

[26]  E. Banks,et al.  Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. , 2012, American journal of human genetics.

[27]  Z. Szallasi,et al.  Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents. , 2012, Cancer discovery.

[28]  Marcel Martin.  Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[29]  C. Perou,et al.  Allele-specific copy number analysis of tumors , 2010, Proceedings of the National Academy of Sciences.

[30]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[31]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[32]  J. Fleiss.  Measuring nominal scale agreement among many raters. , 1971 .